Year | 1997 | 2004 |
---|---|---|
Central nervous system | N = 133 (67.2%) | N = 165 (63.2%) |
Dementia degenerative | n = 65 (32.8%) | n = 97 (37.2%) |
   vascular | n = 57 (28.8%) | n = 80 (30.6%) |
Congenital | n = 11 (5.6%) | n = 8 (3.1%) |
Toxic (hepatic, uremic, ethylic.) | n = 7 (3.5%) | n = 14 (5.4%) |
Inflammatory (status post.) | n = 5 (2,5%) | n = 5 (1.9%) |
Epileptic | n = 4 (2%) | n = 8 (3.1%) |
Posttraumatic | n = 4 (2%) | n = 7 (2.7%) |
Joints and vertebra | N = 84 (42.4%) | N = 168 (64.4%) |
Degenerative | n = 71 (35.8%) | n = 153 (58.6%) |
Posttraumatic | n = 11 (5.6%) | n = 25 (9.6%) |
Inflammatory (status post) | n = 6 (3.0%) | n = 24 (9.2%) |
Congenital | n = 3 (1.5%) | n = 5 (1.9%) |
Cardiorespiratory and vascular system | N = 78 (39.4%) | N = 102 (39%) |
Coronary heart disease and chronic heart failure | n = 70 (35.4%) | n = 84 (32.2%) |
COPD und asthma | n = 11 (5.6%) | n = 30 (11.5%) |
Peripheral arterial occlusive disease | n = 8 (4.0%) | n = 29 (11.1%) |
Metabolic diseases | N = 30 (15.2%) | N = 60 (23.0%) |
Diabetes | n = 22 (11,1%) | n = 49 (18.8%) |
Hepatic | n = 6 (3.0%) | n = 10 (3.8%) |
Renal | n = 7 (3.5%) | n = 7 (2.7%) |
Other diseases | N = 64 (32.3%) | N = 63 (24.1%) |
Marasmus senilis | n = 38 (19.2%) | n = 25(9.6%) |
Blindness | n = 14 (7.1%) | n = 25 (9.6%) |
Deafness | n = 14 (7.1%) | n = 18 (6.9%) |
Terminal malignant disease | n = 10 (5.1%) | n = 11 (4.2%) |